Medical Futurist September 15, 2020

Regulatory authorities such as the U.S. Food & Drug Administration (FDA) and the European Medicine Agency (EMA) are heavily regulating the medical landscape when it comes to artificial intelligence (A.I.)-based solutions. The FDA, in particular, took the lead, having issued a specific framework for A.I.-based algorithms. 

However, even this leading authority, like other regulatory bodies, does not provide a comprehensive database of these tools that it has approved. One can expect such information to be readily available, especially for a prominent technology like A.I. But the very authorities regulating the landscape failed to provide it.

It’s a booming market and it’s not because of its hype. The number of life science studies published around A.I. rose from 596 in 2010 to 12,422 in 2019....